MEDIFAST Historical Income Statement

MED Stock

USD 18.50 0.20 1.09%

Historical analysis of MEDIFAST INC income statement accounts such as Total Revenue of 1.1 B can show how well MEDIFAST INC performed in making a profits. Evaluating MEDIFAST INC income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of MEDIFAST INC's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining MEDIFAST INC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MEDIFAST INC is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

About MEDIFAST Income Statement Analysis

MEDIFAST INC Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to MEDIFAST INC shareholders. The income statement also shows MEDIFAST investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

MEDIFAST INC Income Statement Chart

At present, MEDIFAST INC's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 678.4 M, whereas Net Income From Continuing Ops is forecasted to decline to about 73.5 M.

Depreciation And Amortization Selling General Administrative Total Revenue Gross Profit Other Operating Expenses

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Total Revenue

Total revenue comprises all receipts MEDIFAST INC generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of MEDIFAST INC minus its cost of goods sold. It is profit before MEDIFAST INC operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of MEDIFAST INC. It is also known as MEDIFAST INC overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from MEDIFAST INC's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 678.4 M, whereas Net Income From Continuing Ops is forecasted to decline to about 73.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.1B	1.1B	775.9M	814.6M
Total Revenue	1.5B	1.6B	1.1B	1.1B

Gross Profit Total Revenue

MEDIFAST INC income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Extraordinary Items	Net Income From Continuing Ops	Research Development	Non Operating Income Net Other	Selling And Marketing Expenses	Discontinued Operations	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		-0.07	0.74	0.73	0.72	0.74	0.62	0.63	0.67	0.75	0.74	0.63	0.21	0.61	0.67	-0.21	0.56	0.44	-0.17	-0.32	0.11	0.6	0.32	-0.31	0.69
Interest Expense	-0.07		0.3	0.3	0.31	0.29	0.35	0.35	0.33	0.26	0.3	0.35	0.34	0.37	0.25	-0.51	0.33	0.33	-0.48	-0.45	0.42	0.22	0.22	0.39	0.25
Selling General Administrative	0.74	0.3		1.0	1.0	1.0	0.98	0.98	0.99	1.0	1.0	0.98	0.14	0.98	0.96	-0.71	0.94	0.84	-0.54	-0.74	0.56	0.94	0.28	-0.19	0.79
Total Revenue	0.73	0.3	1.0		1.0	1.0	0.98	0.99	0.99	1.0	1.0	0.99	0.13	0.98	0.97	-0.71	0.95	0.84	-0.55	-0.74	0.56	0.95	0.28	-0.2	0.8
Gross Profit	0.72	0.31	1.0	1.0		1.0	0.99	0.99	0.99	0.99	1.0	0.99	0.13	0.99	0.97	-0.72	0.95	0.84	-0.55	-0.75	0.57	0.95	0.27	-0.19	0.79
Other Operating Expenses	0.74	0.29	1.0	1.0	1.0		0.98	0.98	0.99	1.0	1.0	0.98	0.14	0.98	0.96	-0.71	0.94	0.84	-0.54	-0.73	0.56	0.94	0.28	-0.2	0.8
Operating Income	0.62	0.35	0.98	0.98	0.99	0.98		1.0	1.0	0.97	0.98	1.0	0.09	1.0	0.98	-0.75	0.97	0.86	-0.58	-0.78	0.6	0.97	0.21	-0.18	0.74
Ebit	0.63	0.35	0.98	0.99	0.99	0.98	1.0		1.0	0.97	0.98	1.0	0.09	1.0	0.98	-0.76	0.97	0.86	-0.58	-0.78	0.61	0.97	0.22	-0.17	0.75
Ebitda	0.67	0.33	0.99	0.99	0.99	0.99	1.0	1.0		0.98	0.99	1.0	0.1	1.0	0.98	-0.74	0.96	0.85	-0.57	-0.77	0.59	0.97	0.23	-0.19	0.76
Cost Of Revenue	0.75	0.26	1.0	1.0	0.99	1.0	0.97	0.97	0.98		1.0	0.97	0.13	0.97	0.96	-0.69	0.94	0.84	-0.54	-0.73	0.55	0.94	0.29	-0.22	0.82
Total Operating Expenses	0.74	0.3	1.0	1.0	1.0	1.0	0.98	0.98	0.99	1.0		0.98	0.14	0.98	0.96	-0.71	0.94	0.84	-0.54	-0.74	0.56	0.94	0.28	-0.19	0.79
Income Before Tax	0.63	0.35	0.98	0.99	0.99	0.98	1.0	1.0	1.0	0.97	0.98		0.1	1.0	0.98	-0.76	0.97	0.86	-0.58	-0.78	0.61	0.97	0.22	-0.17	0.74
Total Other Income Expense Net	0.21	0.34	0.14	0.13	0.13	0.14	0.09	0.09	0.1	0.13	0.14	0.1		0.11	0.05	-0.18	0.05	0.15	-0.06	-0.18	0.15	0.0	0.87	0.73	0.35
Net Income	0.61	0.37	0.98	0.98	0.99	0.98	1.0	1.0	1.0	0.97	0.98	1.0	0.11		0.97	-0.77	0.96	0.86	-0.6	-0.78	0.62	0.96	0.24	-0.13	0.74
Income Tax Expense	0.67	0.25	0.96	0.97	0.97	0.96	0.98	0.98	0.98	0.96	0.96	0.98	0.05	0.97		-0.7	0.95	0.84	-0.52	-0.74	0.57	0.98	0.15	-0.26	0.72
Extraordinary Items	-0.21	-0.51	-0.71	-0.71	-0.72	-0.71	-0.75	-0.76	-0.74	-0.69	-0.71	-0.76	-0.18	-0.77	-0.7		-0.71	-0.83	0.73	0.92	-0.85	-0.65	-0.32	-0.26	-0.56
Net Income From Continuing Ops	0.56	0.33	0.94	0.95	0.95	0.94	0.97	0.97	0.96	0.94	0.94	0.97	0.05	0.96	0.95	-0.71		0.91	-0.56	-0.77	0.61	0.96	0.17	-0.21	0.77
Research Development	0.44	0.33	0.84	0.84	0.84	0.84	0.86	0.86	0.85	0.84	0.84	0.86	0.15	0.86	0.84	-0.83	0.91		-0.64	-0.89	0.82	0.82	0.28	-0.03	0.77
Non Operating Income Net Other	-0.17	-0.48	-0.54	-0.55	-0.55	-0.54	-0.58	-0.58	-0.57	-0.54	-0.54	-0.58	-0.06	-0.6	-0.52	0.73	-0.56	-0.64		0.78	-0.74	-0.5	-0.25	-0.14	-0.52
Selling And Marketing Expenses	-0.32	-0.45	-0.74	-0.74	-0.75	-0.73	-0.78	-0.78	-0.77	-0.73	-0.74	-0.78	-0.18	-0.78	-0.74	0.92	-0.77	-0.89	0.78		-0.89	-0.68	-0.3	-0.17	-0.59
Discontinued Operations	0.11	0.42	0.56	0.56	0.57	0.56	0.6	0.61	0.59	0.55	0.56	0.61	0.15	0.62	0.57	-0.85	0.61	0.82	-0.74	-0.89		0.51	0.26	0.22	0.45
Tax Provision	0.6	0.22	0.94	0.95	0.95	0.94	0.97	0.97	0.97	0.94	0.94	0.97	0.0	0.96	0.98	-0.65	0.96	0.82	-0.5	-0.68	0.51		0.11	-0.31	0.74
Interest Income	0.32	0.22	0.28	0.28	0.27	0.28	0.21	0.22	0.23	0.29	0.28	0.22	0.87	0.24	0.15	-0.32	0.17	0.28	-0.25	-0.3	0.26	0.11		0.71	0.53
Net Interest Income	-0.31	0.39	-0.19	-0.2	-0.19	-0.2	-0.18	-0.17	-0.19	-0.22	-0.19	-0.17	0.73	-0.13	-0.26	-0.26	-0.21	-0.03	-0.14	-0.17	0.22	-0.31	0.71		-0.05
Reconciled Depreciation	0.69	0.25	0.79	0.8	0.79	0.8	0.74	0.75	0.76	0.82	0.79	0.74	0.35	0.74	0.72	-0.56	0.77	0.77	-0.52	-0.59	0.45	0.74	0.53	-0.05

Click cells to compare fundamentals

MEDIFAST INC Account Relationship Matchups

MEDIFAST INC income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	4.6M	7.3M	11.9M	17.1M	13.1M	13.8M
Interest Expense	5.9M	7.4M	231K	701K	2.5M	2.6M
Selling General Administrative	445.8M	563.7M	909.8M	953.9M	646.0M	678.4M
Total Revenue	713.7M	934.8M	1.5B	1.6B	1.1B	1.1B
Gross Profit	536.9M	697.8M	1.1B	1.1B	775.9M	814.6M
Other Operating Expenses	622.6M	800.7M	1.3B	1.4B	945.7M	992.9M
Operating Income	91.0M	134.2M	216.2M	184.8M	126.4M	132.7M
Ebit	91.0M	134.2M	211.2M	184.8M	126.4M	132.7M
Ebitda	95.7M	141.4M	223.1M	201.8M	139.5M	146.5M
Cost Of Revenue	176.8M	237.0M	398.5M	458.2M	296.2M	311.0M
Total Operating Expenses	445.8M	563.7M	911.4M	955.6M	649.4M	681.9M
Income Before Tax	92.4M	134.3M	216.1M	184.1M	128.8M	135.2M
Total Other Income Expense Net	1.3M	106K	(112K)	(747K)	2.4M	2.5M
Net Income	77.9M	102.9M	164.0M	143.6M	99.4M	104.4M
Income Tax Expense	14.4M	31.4M	52.1M	40.5M	29.4M	30.9M
Net Income Applicable To Common Shares	77.9M	102.9M	164.0M	143.6M	165.1M	173.4M
Net Income From Continuing Ops	77.9M	102.9M	164.0M	143.6M	119.9M	73.5M
Research Development	2.7M	2.8M	4.4M	4.5M	4.6M	2.4M
Non Operating Income Net Other	29K	(140K)	119K	(46K)	(41.4K)	(39.3K)
Selling And Marketing Expenses	5.3M	4.4M	1.6M	1.7M	3.4M	3.2M
Tax Provision	14.4M	31.4M	52.1M	40.5M	31.5M	26.5M
Interest Income	1.3M	246K	231K	701K	2.5M	2.6M
Net Interest Income	1.3M	246K	(231K)	(701K)	1.1M	1.2M
Reconciled Depreciation	4.6M	7.3M	6.8M	11.0M	12.7M	8.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:

How To Invest In MEDIFAST

Details

Is MEDIFAST Stock a good investment?

Details

What is MEDIFAST INC's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.95)

Earnings Share

0.67

Revenue Per Share

61.769

Quarterly Revenue Growth

(0.41)

Return On Assets

0.0477

The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MEDIFAST Historical Income Statement

About MEDIFAST Income Statement Analysis

MEDIFAST INC Income Statement Chart

Depreciation And Amortization

Total Revenue

Gross Profit

Other Operating Expenses

MEDIFAST INC income statement Correlations

MEDIFAST INC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MEDIFAST INC income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Revenue	+ 1.0	Selling General Administrative
Gross Profit	+ 1.0	Selling General Administrative
Other Operating Expenses	+ 1.0	Selling General Administrative
Cost Of Revenue	+ 1.0	Selling General Administrative
Total Operating Expenses	+ 1.0	Selling General Administrative
Gross Profit	+ 1.0	Total Revenue

Discontinued Operations	- 0.89	Selling And Marketing Expenses
Selling And Marketing Expenses	- 0.89	Research Development
Discontinued Operations	- 0.85	Extraordinary Items
Research Development	- 0.83	Extraordinary Items
Selling And Marketing Expenses	- 0.78	Net Income
Selling And Marketing Expenses	- 0.78	Income Before Tax